account_id none on file
legal_name Arcadia Biosciences, Inc.
ticker RKDA
cik 1469443
domain arcadiabio.com
linkedin_company_url https://www.linkedin.com/company/arcadia-biosciences
entry_point_account_id none on file
name Arcadia Biosciences Inc.
exchange Nasdaq
sector Consumer Staples
hq Dallas, TX, United States
sector index/company/sector/consumer-staples/
calls 0 filings 11 executives 6 family 0
why_nownone on file
callsnone on file
filings
Chair of the Board of Directors Lilian Shackelford Murray
filing / Aug 10, 2026 / receipt
Lilian Shackelford Murray 67 Director
filing / Aug 10, 2026 / receipt
Amy Yoder 59 Director
filing / Aug 10, 2026 / receipt
Gregory D. Waller 76 Director
filing / Aug 10, 2026 / receipt
Thomas J. Schaefer was appointed as our President and Chief Executive Officer in July 2024
filing / Aug 10, 2026 / receipt
Nominees for Director Gregory D. Waller has served as a director of the Company since June 2017
filing / Aug 10, 2026 / receipt
Other Directors Kevin Comcowich has served as a director of our Company since November 2016
filing / Aug 10, 2026 / receipt
Thomas J. Schaefer. See above under the heading “Executive Officers” for information regarding Mr. Schaefer. We believe Mr. Schaefer is qualified to serve on the Board
filing / Aug 10, 2026 / receipt
the Class I directors are Kevin Comcowich and Thomas J. Schaefer, whose terms will expire
filing / Aug 10, 2026 / receipt
the Class II director is Gregory D. Waller, whose term will expire at the Meeting
filing / Aug 10, 2026 / receipt
the Class III directors are Amy Yoder and Lilian Shackelford Murray, and their terms will expire
filing / Aug 10, 2026 / receipt
executives
| Amy Yoder | Director | - | receipt |
| Gregory D. Waller | Director nominee | - | receipt |
| Kevin Comcowich | Director | - | receipt |
| Lilian Shackelford Murray | Director | - | receipt |
| Roger Salameh | Interim President and Chief Executive Officer | - | receipt |
| Thomas J. Schaefer | President and Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-06 | earnings call | scheduled | ir |
changes
| 2021-12-20 | Interim Chief Executive Officer, appointed | sec_8k |
| 2016-11-02 | director, appointed | sec_8k |
| 2016-02-12 | Interim President and Chief Executive Officer, appointed | sec_8k |
mcp_package_hint
slug arcadia-biosciences-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$